JPWO2023054669A1 - - Google Patents
Info
- Publication number
- JPWO2023054669A1 JPWO2023054669A1 JP2023551894A JP2023551894A JPWO2023054669A1 JP WO2023054669 A1 JPWO2023054669 A1 JP WO2023054669A1 JP 2023551894 A JP2023551894 A JP 2023551894A JP 2023551894 A JP2023551894 A JP 2023551894A JP WO2023054669 A1 JPWO2023054669 A1 JP WO2023054669A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021161918 | 2021-09-30 | ||
| PCT/JP2022/036673 WO2023054669A1 (ja) | 2021-09-30 | 2022-09-30 | 眼科組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023054669A1 true JPWO2023054669A1 (https=) | 2023-04-06 |
| JPWO2023054669A5 JPWO2023054669A5 (https=) | 2025-10-08 |
Family
ID=85782993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551894A Pending JPWO2023054669A1 (https=) | 2021-09-30 | 2022-09-30 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240390416A1 (https=) |
| EP (1) | EP4393510A4 (https=) |
| JP (1) | JPWO2023054669A1 (https=) |
| TW (1) | TW202320815A (https=) |
| WO (1) | WO2023054669A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250302868A1 (en) * | 2024-03-26 | 2025-10-02 | Ocusoft, Inc. | Hypochlorous acid-based dry eye formulations |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2134376C (en) * | 1993-12-20 | 2001-10-23 | Haresh G. Bhagat | Combinations of polymers for use in physiological tear compositions |
| US20050214382A1 (en) * | 2004-03-29 | 2005-09-29 | Erning Xia | Zinc preservative composition and method of use |
| US20070212420A1 (en) * | 2006-03-10 | 2007-09-13 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
| TWI394564B (zh) | 2006-09-21 | 2013-05-01 | Alcon Res Ltd | 自行保存型水性藥學組成物 |
| CA2717825A1 (en) * | 2008-03-07 | 2009-09-11 | Sun Pharma Advanced Research Company Ltd. | Opthalmic composition |
| WO2011138801A1 (en) * | 2010-05-07 | 2011-11-10 | Sun Pharma Advanced Research Company Ltd. | Novel ophthalmic compositions |
| JP6313599B2 (ja) * | 2011-11-01 | 2018-04-18 | ロート製薬株式会社 | 眼科用水性組成物 |
| TW201322982A (zh) * | 2011-11-01 | 2013-06-16 | Otsuka Pharma Co Ltd | 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑 |
| JP6081173B2 (ja) * | 2011-12-12 | 2017-02-15 | ロート製薬株式会社 | 眼科用水性組成物 |
| JP6150510B2 (ja) * | 2011-12-12 | 2017-06-21 | ロート製薬株式会社 | 眼科用水性組成物 |
| TW201417814A (zh) * | 2012-09-28 | 2014-05-16 | Otsuka Pharma Co Ltd | 包括瑞巴派特之醫藥組成物 |
| JP6027866B2 (ja) * | 2012-11-22 | 2016-11-16 | ロート製薬株式会社 | オロパタジン含有水性組成物 |
| JP6611444B2 (ja) * | 2015-03-24 | 2019-11-27 | ロート製薬株式会社 | 眼科用組成物 |
| CN107614018A (zh) * | 2015-05-28 | 2018-01-19 | 乐敦制药株式会社 | 水性眼科组合物 |
| PH12020551313B1 (en) * | 2018-02-28 | 2024-02-28 | Santen Pharmaceutical Co Ltd | Ophthalmic composition comprising diquafosol and cationic polymer |
| JP7104553B2 (ja) * | 2018-03-30 | 2022-07-21 | ロート製薬株式会社 | 眼科組成物 |
| JP7758466B2 (ja) * | 2019-11-07 | 2025-10-22 | ロート製薬株式会社 | 眼科組成物 |
-
2022
- 2022-09-30 EP EP22876531.9A patent/EP4393510A4/en active Pending
- 2022-09-30 US US18/695,745 patent/US20240390416A1/en active Pending
- 2022-09-30 TW TW111137266A patent/TW202320815A/zh unknown
- 2022-09-30 JP JP2023551894A patent/JPWO2023054669A1/ja active Pending
- 2022-09-30 WO PCT/JP2022/036673 patent/WO2023054669A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| TW202320815A (zh) | 2023-06-01 |
| EP4393510A4 (en) | 2025-08-06 |
| WO2023054669A1 (ja) | 2023-04-06 |
| US20240390416A1 (en) | 2024-11-28 |
| EP4393510A1 (en) | 2024-07-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250930 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250930 |